CNCR vs. BTEC ETF Comparison
Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to Principal Healthcare Innovators Index ETF (BTEC)
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.
Grade (RS Rating)
Last Trade
$14.81
Average Daily Volume
4,197
67
BTEC
Principal Healthcare Innovators Index ETF
BTEC Description
The investment seeks to provide investment results that closely correspond, before expenses, to the performance of the Nasdaq Healthcare Innovators Index (the "index"). Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies that compose the index at the time of purchase. The index uses a quantitative model designed to identify equity securities in the Nasdaq US Benchmark Index (including growth and value stock) that are small and medium capitalization U.S. healthcare companies.Grade (RS Rating)
Last Trade
$39.49
Average Daily Volume
10,388
1
Performance
Period | CNCR | BTEC |
---|---|---|
30 Days | -1.79% | 8.04% |
60 Days | 4.08% | 9.79% |
90 Days | 12.50% | 8.22% |
12 Months | 40.78% | 11.05% |
0 Overlapping Holdings
Symbol | Grade | Weight in CNCR | Weight in BTEC | Overlap |
---|
CNCR Overweight 67 Positions Relative to BTEC
Symbol | Grade | Weight | |
---|---|---|---|
SMMT | D | 6.48% | |
GERN | D | 3.44% | |
ELVN | B | 2.87% | |
NRIX | D | 2.41% | |
IGMS | D | 2.2% | |
FHTX | C | 2.17% | |
ACRV | D | 2.0% | |
RVMD | B | 1.88% | |
JANX | D | 1.87% | |
TYRA | C | 1.87% | |
KYMR | C | 1.78% | |
NUVB | F | 1.76% | |
ERAS | D | 1.75% | |
ACLX | C | 1.74% | |
REPL | C | 1.74% | |
AURA | D | 1.71% | |
BNTX | B | 1.71% | |
NUVL | B | 1.7% | |
TSVT | C | 1.7% | |
EXEL | C | 1.64% | |
REGN | D | 1.6% | |
MRUS | D | 1.51% | |
BCYC | D | 1.47% | |
BPMC | F | 1.44% | |
DAWN | D | 1.41% | |
ITOS | F | 1.39% | |
IMRX | D | 1.39% | |
IMTX | D | 1.38% | |
HCM | D | 1.38% | |
CGEM | F | 1.38% | |
GLUE | D | 1.37% | |
MRK | F | 1.35% | |
BMY | B | 1.34% | |
KURA | D | 1.29% | |
XNCR | D | 1.29% | |
RLAY | F | 1.28% | |
STRO | F | 1.26% | |
IPHA | F | 1.23% | |
YMAB | D | 1.22% | |
RCUS | F | 1.21% | |
GMAB | F | 1.12% | |
SNDX | F | 1.11% | |
IDYA | F | 1.06% | |
SDGR | F | 1.04% | |
LEGN | F | 0.98% | |
ACET | F | 0.98% | |
IOVA | F | 0.96% | |
PGEN | F | 0.95% | |
SWTX | F | 0.93% | |
LYEL | F | 0.91% | |
RPTX | D | 0.91% | |
RXRX | F | 0.87% | |
AUTL | F | 0.86% | |
ALLO | F | 0.84% | |
ARVN | F | 0.76% | |
PRLD | F | 0.75% | |
KPTI | F | 0.73% | |
IMCR | F | 0.72% | |
FATE | F | 0.71% | |
BMEA | D | 0.69% | |
VOR | F | 0.63% | |
MRSN | D | 0.55% | |
CRBU | F | 0.5% | |
GNLX | D | 0.49% | |
ZNTL | D | 0.4% | |
RAPT | F | 0.29% | |
MGNX | F | 0.27% |
CNCR Underweight 1 Positions Relative to BTEC
Symbol | Grade | Weight | |
---|---|---|---|
SCLX | F | -0.09% |
CNCR: Top Represented Industries & Keywords
BTEC: Top Represented Industries & Keywords